ADMA Biologics, Inc. (ADMA)
16.58
+1.01
(+6.49%)
USD |
NASDAQ |
Mar 02, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Research and Development Expense (Annual) : 4.762M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Marker Therapeutics, Inc. | 13.47M |
| Arcutis Biotherapeutics, Inc. | 77.05M |
| CorMedix, Inc. | 3.942M |
| AtriCure, Inc. | 90.17M |
| Ligand Pharmaceuticals, Inc. | 81.18M |